- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04059640
PMCF Study of LiquiBand FIX8® OHMF Device (LBF8-Open)
PMCF Study to Evaluate the Safety and Performance of LiquiBand FIX8® Open Hernia Mesh Fixation Device
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Tina Warburton
- Phone Number: 01606863500
- Email: tina.warburton@admedsol.com
Study Contact Backup
- Name: Rebecca Forder
- Phone Number: 01606863500
- Email: rebecca.forder@admedsol.com
Study Locations
-
-
-
Ashton-under-Lyne, United Kingdom
- Recruiting
- Tameside General Hospital
-
Contact:
- Andrei Mihailescu
-
Great Yarmouth, United Kingdom, NR31 6LA
- Recruiting
- James Paget University Hospitals NHS Foundation Trust
-
Contact:
- Christopher Liao
-
Wirral, United Kingdom, CH49 5PE
- Recruiting
- Wirral University Teaching Hospital NHS Foundation Trust
-
Contact:
- Conor Magee
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Subject is able to understand and give informed consent to take part in the study
- Subject has a primary inguinal hernia.
- Subject is scheduled to undergo open inguinal hernia repair using the LiquiBand FIX8® OHMF device.
- Subject is willing and able to comply with the protocol assessments at time of surgery and during the post-surgical follow-up period.
Exclusion Criteria:
- Subject is undergoing open repair surgery for recurrent hernia, where the primary surgery was also open. Subjects with recurrent hernia whose primary surgery was laparoscopic are not excluded.
- Subject has an anatomical defect or had prior surgical procedures that in the opinion of the investigator makes them unsuitable for open hernia repair with the LiquiBand FIX8® OHMF device.
- Subject is known to be non-compliant with medical treatment.
- Subject is pregnant or actively breastfeeding.
- Subject has any significant or unstable medical or psychiatric condition that, in the opinion of the Investigator, would interfere with his/her ability to participate in the study.
- Subject has a known sensitivity to cyanoacrylate or formaldehyde, D&C Violet No.2 dye or any other component of LiquiBand FIX8® OHMF device.
- The hernia mesh to be used in the repair is constructed from Polytetrafluoroethylene (PTFE) or absorbable materials.
- The hernia mesh to be used in the repair is a self-gripping mesh (e.g. ProGrip).
- Subject has active or potential infection at the surgical site.
- Subject has a history of keloid formation.
- Subject has a known vitamin C or zinc deficiency.
- Subject has a connective tissue disorder.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: LiquiBand FIX8® OHMF Device
Subjects will undergo hernia mesh fixation and topical wound closure using the LiquiBand FIX8® OHMF device.
|
Subjects will undergo hernia mesh fixation and topical wound closure using the LiquiBand FIX8® OHMF device. Subjects will be evaluated intra-operatively, post-operatively, at discharge, and at 12 months post-operatively. The Liquiband surgical study device is considered a permanent implant. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Effectiveness of the LiquiBand FIX8 OHMF device
Time Frame: Time of surgery
|
Effectiveness will be defined as successful fixation of the hernia mesh (ie not requiring additional fixation by an alternate device) using the LiquiBand FIX8 device at the time of surgery.
Based on data pooled from published studies of a similar device (which employs the same cyanoacrylate glue to fix hernia mesh, via a laparoscopic rather than open surgical approach), there has been an observed failure rate of 0.8% in mesh fixation.
This study aims to demonstrate non-inferiority of the LiquiBand FIX8 device to a failure rate of 5% (medically acceptable inference).
|
Time of surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Safety of the LiquiBand FIX8 OHMF device
Time Frame: 0 (intra-operatively), up to 2 days (discharge from hospital) and 12-months post surgery
|
The incidence of adverse events (whether or not determined to be related to the LiquiBand FIX8 Device) will be recorded. Complications assessed during the study will include:
|
0 (intra-operatively), up to 2 days (discharge from hospital) and 12-months post surgery
|
Effectiveness of the LiquiBandFIX8 OHMF device for topical wound closure
Time Frame: Time of surgery
|
Defined as successful closure of the incision site using the LiquiBand FIX8 Device (not requiring additional fixation by an alternate device).
|
Time of surgery
|
Assessment of chronic post-operative pain using the Visual Analogue Scale: the minimal clinically important difference and patient acceptable symptom state.
Time Frame: 12-months post-surgery
|
Chronic post-operative pain will be assessed using the following measures:
|
12-months post-surgery
|
Long term performance of the study device
Time Frame: 12-months post surgery
|
Long-term performance will be assessed by rate of hernia recurrence.
|
12-months post surgery
|
Comparison of cost-effectiveness of patients treated with the LiquiBand FIX8 OHMF device compared with costs for those treated using standard surgical technique.
Time Frame: 12-months
|
A study-specific outcome model will be used, which will calculate an incremental cost effectiveness ratio (ICER) in terms of quality-adjusted life years (QALYs) achieved with the introduction of the LiquiBand FIX8 OHMF device compared with using a standard surgical technique (suture fixation).
|
12-months
|
Comparison of costs of patients' clinical events treated with the LiquiBand FIX8 OHMF device compared with costs for those treated using standard surgical technique.
Time Frame: 12-months
|
A study-specific outcome model will be used which will calculate an incremental cost effectiveness ratio (ICER) given in terms of clinical events avoided achieved with the introduction of the LiquiBand FIX8 OHMF device compared with using a standard surgical technique (suture fixation).
|
12-months
|
Clinician satisfaction
Time Frame: 0 (Post Surgery) and upto 2 days (hospital discharge)
|
Users will be asked to rate the device on factors relating to ease of use and satisfaction, compared with their experience of other hernia mesh fixation devices.
Satisfaction will be assessed using a Likert-type scale (e.g.
Very satisfied (1), Satisfied (2), Neither (3), Dissatisfied (4), Very dissatisfied (5))
|
0 (Post Surgery) and upto 2 days (hospital discharge)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cosmesis of wound closure using the Visual Analogue Scale
Time Frame: 12-months
|
Cosmesis of the wound closure will be assessed by the investigator and patient, and measured by Visual Analogue Scale (0 = Very poor cosmetic outcome; to 10 = very good cosmetic outcome).
|
12-months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Andrei Mihailescu, MD, Tameside & Glossop Integrated Care NHS Foundation Trust
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- OHMF-001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Inguinal Hernia
-
Children's Mercy Hospital Kansas CityRecruitingInguinal Hernia | Inguinal Hernia, Indirect | Inguinal Hernia Unilateral | Inguinal Hernia BilateralUnited States
-
Hospital General Universitario ElcheCompletedInguinal Hernia | Inguinal Hernia Repair | Open Inguinal Hernia
-
San Bonifacio HospitalCompletedIndirect Inguinal Hernia | Direct Inguinal HerniaItaly
-
Bakirkoy Dr. Sadi Konuk Research and Training HospitalEnrolling by invitationInguinal Hernia | Strangulated Inguinal Hernia | Incarcerated Inguinal HerniaTurkey
-
University Hospital, GhentMedriCompleted
-
Ahmadullah DanishCompletedIncarcerated Inguinal HerniaAfghanistan
-
General Hospital of LarissaUnknown
-
Alexandria UniversityCompletedBilateral Inguinal Hernia
-
Hospital Siberia-SerenaUnknownPrimary Inguinal HerniaSpain
-
Diskapi Teaching and Research HospitalCompleted
Clinical Trials on LiquiBand FIX8 Open Hernia Mesh Fixation Device
-
Algemeen Ziekenhuis Maria MiddelaresDuomedRecruitingRecurrence | HerniaBelgium
-
Immanuel Kant Baltic Federal UniversityRecruitingChronic Pain | Inguinal Hernia | Ventral Hernia | Umbilical Hernia | Femoral Hernia | Acute Post Operative Pain | Recrrence RateRussian Federation
-
Rambam Health Care CampusWithdrawn
-
Assiut UniversityNot yet recruiting
-
University of CagliariCompletedSpigelian Hernia
-
Ospedale di Circolo - Fondazione MacchiUnknown
-
Rigshospitalet, DenmarkBaxter Healthcare Corporation; Aesculap AGCompleted
-
US Department of Veterans AffairsCompletedHernia, VentralUnited States
-
Owen Drive Surgical Clinic of FayettevilleMedtronic - MITGUnknownEvaluate the Use of a New Mesh Type in Open Inguinal Hernia RepairUnited States
-
Helsinki University Central HospitalCompleted